RxDoctor Payments Data

Charis Peek

Nurse Practitioner · Scottsboro, ALNPI 1083756472

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 100.0% of the total across 190 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 16 manufacturers reported payments, led by Novo Nordisk at 38.1% of the total. Reporting peaked in 2021 at $925 and has fallen 94.0% since, to $56 in 2025.

$2,871in general payments, 2019–2025

Across 190 payments — averaging $15.11 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Novo Nordisk$1K
  • GSK$732
  • AbbVie$355
  • AstraZeneca$254
  • Novartis$164
  • Lilly USA, LLC$53
  • plus $221 from 10 others

What the payments were for

  • Food & beverage$2,871100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$2,871 in reported general payments places this provider in the 85th percentile of 1,505 nurse practitioner providers in Alabama.

See all nurse practitioner providers in Alabama →

Other nurse practitioner in Scottsboro

See the full list for Alabama →

Where these figures come from

Is this you, or does something look wrong? →